Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Seattle Genetics, Inc. (SGEN)

« Back to company index

SGEN Chatter Timeline

Stock Ticker for SGEN

Most Active Tweeters for SGEN

UserTweets
@Tickeron 7
@newsfilterio 4
@Jarvis_Alerts 3
@FlashAlert_me 3
@mehabecapital 3

Recent Tweets for SGEN

SweepCastApp @SweepCastApp
SweepCast alerted: $SGEN with Unusual Options Activity Alerted on $125 CALL Expiring: 02-18-2022 worth 57K? |? Chec… https://t.co/LU6sxkZ9Cf
January 25th 2022, 12:01pm
SweepCastApp @SweepCastApp
$SGEN Seagen Option Alert: Feb 18 $125 Puts at the Bid: 40 vs 36 OI; Earnings 2/9 After Close ? |? Learn more and g… https://t.co/8ESTKFnS3F
January 25th 2022, 12:01am
Tickeron @Tickeron
$SGEN in Downtrend: 50-day Moving Average broke below 200-day Moving Average on January 21, 2022. View odds for thi… https://t.co/hoRcmgqugP
January 24th 2022, 5:01pm
PenkeTrading @PenkeTrading
I found you a Death Cross on the daily chart of Seagen Inc. $SGEN $SGEN.NASDAQ #deathcross #bearish… https://t.co/NQG2qagu85
January 23rd 2022, 2:01pm
Tikenw1Tikenw @Tikenw1Tikenw
The average discretionary accruals of $SGEN in recent quarters is large, which is higher than 67% of other firms in… https://t.co/tDkwgGdVrf
January 23rd 2022, 8:01am
SeekingAlpha @SeekingAlpha
$SGEN - Seagen (SGEN) Presents At 40th Annual Healthcare Virtual Conference - Slideshow. https://t.co/LX7NPGMzXK… https://t.co/xiLUK5fiSl
January 21st 2022, 11:01pm
jmbiofarm @jmbiofarm
@Aesculapius1898 @reco_plasmid Yeah I mean, he’s already rich from $SGEN but indeed it kinda eye catching. The chai… https://t.co/mdt4dNN2Zj
January 21st 2022, 11:01pm
Danger009Mouse @Danger009Mouse
There are 2 companies in the S&P 500 & NASDAQ 100 that developed a Death Cross today: $TGT, $SGEN
January 21st 2022, 11:01pm
LargeVoidBot @LargeVoidBot
12:16 New 52wk Lows: $SGEN
January 21st 2022, 5:01pm
bthefirsttoknow @bthefirsttoknow
First out// $SGEN: Will Chart Analysts Notice Bad Omen on Seagen's Chart https://t.co/7NIo1EUqtN
January 21st 2022, 2:01pm
InsiderAlerts4U @InsiderAlerts4U
$SGEN: New Insider Filing on Seagen Inc.'s Chief Legal Officer JEAN I LIU: https://t.co/6Egk24ixu7
January 21st 2022, 12:01pm
InsiderAlerts4U @InsiderAlerts4U
$SGEN: New Insider Filing on Seagen Inc.'s Director DAVID W GRYSKA: https://t.co/t5ybKCai6M
January 21st 2022, 8:01am
newsfilterio @newsfilterio
5,915 shares acquired by Liu Jean I (Chief Legal Officer), reported in a new form 4 filed with the SEC $SGEN https://t.co/XgiJcFcnGH
January 21st 2022, 7:01am
FlashAlert_me @FlashAlert_me
$SGEN [15s. delayed] filed SEC form 4: Chief Legal Officer LIU JEAN I: Granted 5,915 of Common Stock at price $0 o… https://t.co/hxsx1qH9Lw
January 21st 2022, 1:01am
formwhisperscom @formwhisperscom
#FWSells $SGEN GRYSKA DAVID W, Director of Seagen Inc. sold 4,500 shares on 2022-01-14. https://t.co/kIhi9GXVrz
January 21st 2022, 1:01am
MC_OptionTrades @MC_OptionTrades
$SGEN 21-Jan-22 Straddle Implies a ±2.4% move. Jan 21 American Society of Clinical Oncology Gastrointestinal Cancer… https://t.co/HhntrUFmoB
January 20th 2022, 7:01pm
SweepCastApp @SweepCastApp
$SGEN Seagen Option Alert: Dec 16 $145 Puts at the Bid: 20 vs 4 OI; Earnings 2/9 After Close ? |? Learn more and ge… https://t.co/AzHjTbnRlB
January 20th 2022, 6:01pm
akhil_mana @akhil_mana
$SGEN Find active market alerts here in this trading community.. Join today to get FREE access to our options, stoc… https://t.co/glOpluyY31
January 20th 2022, 10:01am
newsfilterio @newsfilterio
$518,310.00 of shares sold by Gryska David W (Director), reported in a new form 4 filed with the SEC $SGEN https://t.co/0WptCBJbaz
January 20th 2022, 6:01am
AkashDansi @AkashDansi
$SGEN Find active market alerts here in this trading community.. Join today to get FREE access to our options, stoc… https://t.co/pGvlAPc5l0
January 20th 2022, 3:01am
LeonCha04865190 @LeonCha04865190
$SGEN ~Find active market alerts here in this best trading community.https://t.co/djrvQMKrPs
January 20th 2022, 2:01am
MARIAMA64343933 @MARIAMA64343933
$SGEN Find active market alerts here in this trading community.. Join today to get FREE access to our options, stoc… https://t.co/bj6yrNbQYo
January 20th 2022, 1:01am
Tickeron @Tickeron
$SGEN was this quarter's top loser, falling -25.48% #Seagen https://t.co/cjMgnorvZT
January 20th 2022, 12:01am
akhil_mana @akhil_mana
$SGEN Find active market alerts here in this trading community.. Join today to get FREE access to our options, stoc… https://t.co/ULpLSR2YP2
January 20th 2022, 12:01am
Tickeron @Tickeron
$SGEN in -5.25% Downtrend, sliding for three consecutive days on January 13, 2022. View odds for this and other ind… https://t.co/XIap07cRGn
January 19th 2022, 11:01pm
42Stocks @42Stocks
https://t.co/PV9h3Uu6mA 2022-01-19 6:35 PM $SGEN #SeattleGenetics Seagen up 1.73% = $433.67 million gain.… https://t.co/WUR6usvwmo
January 19th 2022, 11:01pm
FlashAlert_me @FlashAlert_me
$SGEN [15s. delayed] filed SEC form 4: Director GRYSKA DAVID W: Disposed 4,500 of Common Stock at price $135.24 an… https://t.co/8DLlWzQfc9
January 19th 2022, 11:01pm
TO_BioInv @TO_BioInv
@Biohazard3737 $BCYC could be disruptive to $SGEN
January 19th 2022, 6:01pm
evaluatevantage @evaluatevantage
RT @JacobPlieth: Reports of the death of CD40 agonism are greatly exaggerated. Quick take on $SGEN #GI22 via @evaluatevantage https://t.co/…
January 19th 2022, 4:01pm
BertrandBio @BertrandBio
@JacobPlieth @evaluatevantage Nope they're not. These $SGEN data not any different of Apexigen's Gem-NP+nivo cohor… https://t.co/BnhxjT30MR
January 19th 2022, 3:01pm
JacobPlieth @JacobPlieth
Reports of the death of CD40 agonism are greatly exaggerated. Quick take on $SGEN #GI22 via @evaluatevantage… https://t.co/Me3BYEXrCx
January 19th 2022, 3:01pm
akhil_mana @akhil_mana
$SGEN Find active market alerts here in this trading community. Join today to get FREE access to our options, stock… https://t.co/5faT50NwSK
January 19th 2022, 2:01pm
newsfilterio @newsfilterio
Seagen's SEA-CD40 Combo Regime Shows Preliminary Antitumor Activity In Pancreatic Cancer $SGEN $MRK https://t.co/CyOlH5EYuU
January 19th 2022, 2:01pm
Jarvis_Alerts @Jarvis_Alerts
$SGEN 145C Exp:18-Feb-22 -- ? Total(Day): $27,920 #UnusualActivity Sign-up free for beta ver.:… https://t.co/E8l2imWUgU
January 19th 2022, 1:01pm
mehabecapital @mehabecapital
$SGEN @ 130.29 (-4.96%) : Seagen presents early stage data on SEA-CD40 in combination for pancreatic cancer https://t.co/wqsLC926ep
January 19th 2022, 7:01am
MarcJacksonLA @MarcJacksonLA
$SGEN Seagen Reports Data From SEA-CD40 in Combination With Other Therapies in Metastatic Pancreatic Ductal Adenoca… https://t.co/cXZLSeWu0s
January 19th 2022, 1:01am
mehabecapital @mehabecapital
$SGEN @ 130.29 (-4.96%) : Seagen presents early stage data on SEA-CD40 in combination for pancreatic cancer https://t.co/uT5XGCiNa2
January 19th 2022, 1:01am
mehabecapital @mehabecapital
$SGEN @ 130.29 (-4.96%) : Seagen presents early stage data on SEA-CD40 in combination for pancreatic cancer https://t.co/RVRknBWlJ5
January 18th 2022, 10:01pm
MarketCurrents @MarketCurrents
$SGEN - Seagen presents early stage data on SEA-CD40 in combination for pancreatic cancer https://t.co/RTpuuVEwcV
January 18th 2022, 10:01pm
otcdynamics @otcdynamics
$SGEN Seagen Reports Data From SEA-CD40 in Combination With Other Therapies in Metastatic Pancreatic Ductal Adenoca… https://t.co/8oCkDloWlH
January 18th 2022, 10:01pm
vtmtrading @vtmtrading
Seagen announces data from SEA-CD40 combination trial at ASCO GI $SGEN
January 18th 2022, 10:01pm
phasefivebot @phasefivebot
$SGEN Seagen Reports Data From SEA-CD40 in Combination With Other Therapies in Metastatic Pancreatic Ductal Adenoca… https://t.co/jzEw65K0gY
January 18th 2022, 10:01pm
Jarvis_Alerts @Jarvis_Alerts
$SGEN 145C Exp:18-Feb-22 -- ? Total(Day): $27,920 #UnusualActivity Sign-up free for beta ver.:… https://t.co/CBCLZ10ulm
January 18th 2022, 10:01pm
StockNewsBot2 @StockNewsBot2
$SGEN Seagen Reports Data From SEA-CD40 in Combination With Other Therapies in Metastatic Pancreatic Ductal Adenoca… https://t.co/RqtRstfaQf
January 18th 2022, 10:01pm
hephaistos_ai @hephaistos_ai
RT @stock_titan: $SGEN Seagen Reports Data From SEA-CD40 in Combination With Other Therapies in Metastatic Pancreatic Ductal Adenocarcinoma…
January 18th 2022, 10:01pm
stock_titan @stock_titan
$SGEN Seagen Reports Data From SEA-CD40 in Combination With Other Therapies in Metastatic Pancreatic Ductal Adenoca… https://t.co/eY4ukl8mC3
January 18th 2022, 10:01pm
WebChronicleTo1 @WebChronicleTo1
$SGEN Seagen Reports Data From SEA-CD40 in Combination With Other Therapies in Metastatic Pancreatic Ductal Adenoca… https://t.co/ZJILbxSDeW
January 18th 2022, 10:01pm
bthefirsttoknow @bthefirsttoknow
First out// $SGEN: Seagen Reports Data From SEA-CD40 in Combination With Other Therapies in Metastatic Pancreatic D… https://t.co/33jhkfaE8t
January 18th 2022, 10:01pm
Tickeron @Tickeron
$SGEN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/UP40E5G8tU
January 18th 2022, 9:01pm
StckPro @StckPro
$SGEN NEW ARTICLE : Morgan Stanley Remains a Hold on Seagen (SGEN) https://t.co/BXWhpigtwp Get all the latest $SGEN… https://t.co/FUPV3H7pve
January 18th 2022, 5:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.